Luke Greenwalt, MBA, on "Entering a Brave New World" | Asembia's AXS25 Summit
The vice president and market lead of IQVIA's Market Center of Excellence gives some insight intot the title of his talk today at Asembia meeting.
In an interview with Managed Healthcare Executive (MHE), Luke Greenwalt, MBA, vice president and lead of the Market Access Center of Excellence of IQVIA, discusses broad trends in the pharmaceutical market. Greenwalt, who is a member of the MHE editorial advisory board, described the system as a mature one, with three pharmacy benefit members (PBMs) controlling 80% of the prescription market, three wholesalers controlling 90% of distribution and four retail pharmacy chains controlling more than half of retail sales. Now with the Trump administration, major policy changes are possible in the form of tariffs and international pricing.
"It's hard for the big to get any bigger, so we're looking at a marketplace that's going to change pretty dramatically in the next few years," Greenwalt said.
GLP-1 Tiering Agreement Reached, Says Optum Rx President
May 3rd 2024Health plans that use Optum Rx as their pharmacy benefit manager (PBM) will be allowed to tier their coverage of GLP-1s and still receive rebates under an agreement the PBM has reached with the manufacturers, says the PBM president. Optum officials said later that the negotiations were still ongoing,
Read More
Specialty Pharmacies Drive Cost Savings in Value-Based Care | Asembia 2024
May 2nd 2024Earlier this week at the 2024 Asembia Specialty Pharmacy Summit in Las Vegas, Managed Healthcare Executive editors spoke with Bill McElnea, vice president of population health at Shields Health Solutions, about specialty pharmacies reducing costs for patients.
Read More
